Related Experiment Video
Updated: Jun 21, 2026

08:54
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Time resolved analysis of risperidone and 9-hydroxy-risperidone in hair using LC/MS-MS
Serge Schneider1, Estelle Sibille, Michel Yegles
1Laboratoire National de Santé, Division de Toxicologie, Université du Luxembourg, 162a, avenue de la Faïencerie, L-1511 Luxembourg, Luxembourg. serge.schneider@lns.etat.lu
Summary
This study presents a new method for detecting risperidone (RSP) and its metabolite in hair, offering a reliable way to monitor antipsychotic treatment. The findings suggest the metabolite better reflects the administered dose in hair analysis.
Area of Science:
- Forensic Toxicology
- Pharmacokinetics
- Analytical Chemistry
Background:
- Risperidone (RSP) is a crucial second-generation antipsychotic for schizophrenia and anxiety.
- Hair analysis offers a wide surveillance window for drug monitoring.
- Quantifying RSP and its metabolite in hair is vital for treatment adherence and pharmacokinetic studies.
Purpose of the Study:
- To develop and validate a simple, fast method for detecting and quantifying risperidone (RSP) and 9-hydroxy-risperidone (9-OH-RSP) in human hair.
- To apply the validated method to analyze hair samples from psychiatric patients undergoing RSP treatment.
- To investigate the relationship between administered dose and drug concentration in hair for both RSP and its metabolite.
Main Methods:
- Hair sample preparation involved washing, pulverization, ultrasound-assisted incubation, and liquid/liquid extraction.
- Quantification was performed using Liquid Chromatography-Tandem Mass Spectrometry (LC/MS-MS) in selected reaction monitoring mode.
- Methaqualone was used as the internal standard for accurate quantification.
Main Results:
- The validated method demonstrated high precision (CV <15%), accuracy, and sensitivity (LOD as low as 0.90 pg/mg for RSP).
- RSP concentrations in patient hair ranged from 36 to 4765 pg/mg, and 9-OH-RSP from 14 to 57 pg/mg.
- Preliminary data indicated a stronger correlation between administered dose and hair concentration for 9-OH-RSP compared to RSP.
Conclusions:
- A robust LC/MS-MS method for RSP and 9-OH-RSP in hair was successfully developed and validated.
- The method enables the quantification of antipsychotic drug levels in psychiatric patients' hair.
- 9-OH-RSP may serve as a more reliable biomarker than RSP for assessing long-term drug exposure and adherence in hair analysis.

